🟢 Tiziana Life Sciences is trading 5% up in pre-market after Phase 2a BANYAN trial poster announcement

Tiziana Life Sciences is trading 5.22% up now at $1.21 after announcing a Phase 2a BANYAN trial poster presentation at ALS Nexus 2026 on August 24, 2026.

• The release described the study design and planned assessments, but reported no new BANYAN efficacy or safety results.
• Broader risk appetite may also be supporting the move, with Nasdaq futures up 0.95% and the S&P 500 up 0.47%.